OUR PIPELINE

We are focused on the development and commercialisation of clinical-stage oncology programs.


Telix Pharmaceuticals is focused on the development and commercialisation of several clinical-stage oncology assets in renal cancer, prostate cancer and brain cancer.

We are also actively exploring indication expansion opportunities for our programs and platforms as they reflect diagnostic and therapeutic approaches that may be relevant to other important clinical applications.